Skip to main content
Erschienen in: Obesity Surgery 12/2019

05.08.2019 | Original Contributions

Long-term outcomes of laparoscopic sleeve gastrectomy from the Indian subcontinent

verfasst von: Shivanshu Misra, Siddhartha Bhattacharya, S. Saravana Kumar, B. Deepa Nandhini, S. Christinajoice Saminathan, P. Praveen Raj

Erschienen in: Obesity Surgery | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Laparoscopic sleeve gastrectomy (LSG) is the most commonly performed metabolic surgery worldwide. There are few mid- to long-term studies for LSG, especially from the Indian subcontinent.

Objective

The primary outcome of the study was percent total weight loss (%TWL), and secondary outcomes included type 2 diabetes mellitus remission (T2DM) rates, comorbidity resolution rates, revisional surgeries, and complications related to LSG, 3 and 5 years after surgery.

Method

The study was a single-center, retrospective analysis from patients who underwent primary as well as revisional LSG between January 2012 and December 2013 from a tertiary care center in India. We included patients who completed a minimum follow-up of 5 years. Details of the patients were collected from outpatient and inpatient case sheet records, during their follow-up.

Results

Out of a total of 284 patients, 57% were females. Mean baseline body mass index (BMI) was 44.9 ± 7.9 kg/m2. The diabetic population comprised 14.8% of the total patients. Mean %TWL at 5 years was 26.0 ± 9.9%. T2DM remission at 1, 3, and 5 years were 78.5%, 71.4%, and 66.6%, respectively. Preoperative BMI (p = 0.02), glycosylated hemoglobin (HbA1c) (p = 0.04), duration of diabetes in years (p = 0.04), and preoperative insulin usage (p = 0.04) were the preoperative predictors for T2DM remission. Early (< 30 days) and late (> 30 days) complications were seen in 4.5% and 0.7% of the population, respectively.

Conclusion

Weight loss after LSG was maintained in the majority of the patients, while a small proportion has significant weight regain at 5 years. T2DM resolution and other comorbidity resolutions were well supported after LSG.
Literatur
1.
Zurück zum Zitat Kowalewski PK, Olszewski R, Walędziak MS, et al. Long-term outcomes of laparoscopic sleeve gastrectomy—a single-center, retrospective study. Obes Surg. 2018;28(1):130–4.PubMed Kowalewski PK, Olszewski R, Walędziak MS, et al. Long-term outcomes of laparoscopic sleeve gastrectomy—a single-center, retrospective study. Obes Surg. 2018;28(1):130–4.PubMed
2.
Zurück zum Zitat Arias E, Martínez PR, Li VK, et al. Mid-term follow-up after sleeve gastrectomy as a final approach for morbid obesity. Obes Surg. 2009;19(5):544–8.PubMed Arias E, Martínez PR, Li VK, et al. Mid-term follow-up after sleeve gastrectomy as a final approach for morbid obesity. Obes Surg. 2009;19(5):544–8.PubMed
3.
Zurück zum Zitat Abelson JS, Afaneh C, Dolan P, et al. Laparoscopic sleeve gastrectomy: co-morbidity profiles and intermediate-term outcomes. Obes Surg. 2016;26(8):1788–93.PubMed Abelson JS, Afaneh C, Dolan P, et al. Laparoscopic sleeve gastrectomy: co-morbidity profiles and intermediate-term outcomes. Obes Surg. 2016;26(8):1788–93.PubMed
4.
Zurück zum Zitat Wang X, Chang XS, Gao L, et al. Effectiveness of laparoscopic sleeve gastrectomy for weight loss and obesity-associated co-morbidities: a 3-year outcome from mainland Chinese patients. Surg Obes Relat Dis. 2016;12(7):1305–11.PubMed Wang X, Chang XS, Gao L, et al. Effectiveness of laparoscopic sleeve gastrectomy for weight loss and obesity-associated co-morbidities: a 3-year outcome from mainland Chinese patients. Surg Obes Relat Dis. 2016;12(7):1305–11.PubMed
5.
Zurück zum Zitat Boza C, Daroch D, Barros D, et al. Long-term outcomes of laparoscopic sleeve gastrectomy as a primary bariatric procedure. Surg Obes Relat Dis. 2014;10(6):1129–33.PubMed Boza C, Daroch D, Barros D, et al. Long-term outcomes of laparoscopic sleeve gastrectomy as a primary bariatric procedure. Surg Obes Relat Dis. 2014;10(6):1129–33.PubMed
6.
Zurück zum Zitat Sepúlveda M, Alamo M, Saba J, et al. Long-term weight loss in laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2017;13(10):1676–81.PubMed Sepúlveda M, Alamo M, Saba J, et al. Long-term weight loss in laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2017;13(10):1676–81.PubMed
7.
Zurück zum Zitat Garg H, Aggarwal S, Misra MC, et al. Mid to long term outcomes of laparoscopic sleeve gastrectomy in Indian population: 3–7-year results—a retrospective cohort study. Int J Surg. 2017;48:201–9.PubMed Garg H, Aggarwal S, Misra MC, et al. Mid to long term outcomes of laparoscopic sleeve gastrectomy in Indian population: 3–7-year results—a retrospective cohort study. Int J Surg. 2017;48:201–9.PubMed
8.
Zurück zum Zitat Benedix F, Krause T, Adolf D, et al. Perioperative course, weight loss and resolution of comorbidities after primary sleeve gastrectomy for morbid obesity: are their differences between adolescents and adults? Obes Surg. 2017;27(9):2388–97.PubMed Benedix F, Krause T, Adolf D, et al. Perioperative course, weight loss and resolution of comorbidities after primary sleeve gastrectomy for morbid obesity: are their differences between adolescents and adults? Obes Surg. 2017;27(9):2388–97.PubMed
9.
Zurück zum Zitat Dicker D, Yahalom R, Comaneshter DS, et al. Long-term outcomes of three types of bariatric surgery on obesity and type 2 diabetes control and remission. Obes Surg. 2016;26(8):1814–20.PubMed Dicker D, Yahalom R, Comaneshter DS, et al. Long-term outcomes of three types of bariatric surgery on obesity and type 2 diabetes control and remission. Obes Surg. 2016;26(8):1814–20.PubMed
10.
Zurück zum Zitat Juodeikis Ž, Brimas G. Long-term results after sleeve gastrectomy: a systematic review. Surg Obes Relat Dis. 2017;13(4):693–9.PubMed Juodeikis Ž, Brimas G. Long-term results after sleeve gastrectomy: a systematic review. Surg Obes Relat Dis. 2017;13(4):693–9.PubMed
11.
Zurück zum Zitat Casella G, Soricelli E, Giannotti D, et al. Long-term results after laparoscopic sleeve gastrectomy in a large monocentric series. Surg Obes Relat Dis. 2016;12(4):757–62.PubMed Casella G, Soricelli E, Giannotti D, et al. Long-term results after laparoscopic sleeve gastrectomy in a large monocentric series. Surg Obes Relat Dis. 2016;12(4):757–62.PubMed
12.
Zurück zum Zitat Yajnik CS, Yudkin JS. The YY paradox. Lancet. 2004;363(9403):163.PubMed Yajnik CS, Yudkin JS. The YY paradox. Lancet. 2004;363(9403):163.PubMed
13.
Zurück zum Zitat Eastwood SV, Tillin T, Wright A, et al. Thigh fat and muscle each contribute to excess cardiometabolic risk in south Asians, independent of visceral adipose tissue. Obesity. 2014;22(9):2071–9.PubMed Eastwood SV, Tillin T, Wright A, et al. Thigh fat and muscle each contribute to excess cardiometabolic risk in south Asians, independent of visceral adipose tissue. Obesity. 2014;22(9):2071–9.PubMed
14.
Zurück zum Zitat Shrivastava U, Misra A, Mohan V, et al. Obesity, diabetes and cardiovascular diseases in India: public health challenges. Curr Diabetes Rev. 2017;13(1):65–80.PubMed Shrivastava U, Misra A, Mohan V, et al. Obesity, diabetes and cardiovascular diseases in India: public health challenges. Curr Diabetes Rev. 2017;13(1):65–80.PubMed
15.
Zurück zum Zitat Shah RV, Murthy VL, Abbasi SA, et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA study. JACC Cardiovasc Imaging. 2014;7(12):1221–35.PubMedPubMedCentral Shah RV, Murthy VL, Abbasi SA, et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA study. JACC Cardiovasc Imaging. 2014;7(12):1221–35.PubMedPubMedCentral
16.
Zurück zum Zitat Després JP, Couillard C, Gagnon J, et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the health, risk factors, exercise training, and genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol. 2000;20(8):1932–8.PubMed Després JP, Couillard C, Gagnon J, et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the health, risk factors, exercise training, and genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol. 2000;20(8):1932–8.PubMed
17.
Zurück zum Zitat Katzmarzyk PT, Bray GA, Greenway FL, et al. Racial differences in abdominal depot–specific adiposity in white and African American adults. Am J Clin Nutr. 2009;91(1):7–15.PubMedPubMedCentral Katzmarzyk PT, Bray GA, Greenway FL, et al. Racial differences in abdominal depot–specific adiposity in white and African American adults. Am J Clin Nutr. 2009;91(1):7–15.PubMedPubMedCentral
18.
Zurück zum Zitat Mohan V, Amutha A, Ranjani H, et al. Associations of β-cell function and insulin resistance with youth-onset type 2 diabetes and prediabetes among Asian Indians. Diabetes Technol Ther. 2013;15(4):315–22.PubMed Mohan V, Amutha A, Ranjani H, et al. Associations of β-cell function and insulin resistance with youth-onset type 2 diabetes and prediabetes among Asian Indians. Diabetes Technol Ther. 2013;15(4):315–22.PubMed
19.
Zurück zum Zitat Kasama K, Mui W, Lee WJ, et al. IFSO-APC consensus statements 2011. Obes Surg. 2012;22(5):677–84.PubMed Kasama K, Mui W, Lee WJ, et al. IFSO-APC consensus statements 2011. Obes Surg. 2012;22(5):677–84.PubMed
20.
Zurück zum Zitat Vakil N, Van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900–20.PubMed Vakil N, Van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900–20.PubMed
21.
Zurück zum Zitat Hamad GG, Choban PS. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study. Obes Surg. 2005;15(10):1368–74.PubMed Hamad GG, Choban PS. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study. Obes Surg. 2005;15(10):1368–74.PubMed
22.
Zurück zum Zitat Scholten DJ, Hoedema RM, Scholten SE. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg. 2002;12(1):19–24.PubMed Scholten DJ, Hoedema RM, Scholten SE. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg. 2002;12(1):19–24.PubMed
23.
Zurück zum Zitat Snehalatha C, Viswanathan V, Ramachandran A. Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care. 2003;26(5):1380–4.PubMed Snehalatha C, Viswanathan V, Ramachandran A. Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care. 2003;26(5):1380–4.PubMed
24.
Zurück zum Zitat Montero PN, Stefanidis D, Norton HJ, et al. Reported excess weight loss after bariatric surgery could vary significantly depending on calculation method: a plea for standardization. Surg Obes Relat Dis. 2011;7(4):531–4.PubMed Montero PN, Stefanidis D, Norton HJ, et al. Reported excess weight loss after bariatric surgery could vary significantly depending on calculation method: a plea for standardization. Surg Obes Relat Dis. 2011;7(4):531–4.PubMed
25.
Zurück zum Zitat Coelho D, Godoy EP, Marreiros I, et al. Diabetes remission rate in different BMI grades following Roux-en-Y gastric bypass. ABCD. Arq Bras Cir Dig (São Paulo). 2018;31(1) Coelho D, Godoy EP, Marreiros I, et al. Diabetes remission rate in different BMI grades following Roux-en-Y gastric bypass. ABCD. Arq Bras Cir Dig (São Paulo). 2018;31(1)
26.
Zurück zum Zitat Benaiges D, Climent E, Goday A, et al. Bariatric surgery and hypertension: implications and perspectives after the GATEWAY randomized trial. Cardiovasc Diagn Ther. 2019;9(1):100–3.PubMedPubMedCentral Benaiges D, Climent E, Goday A, et al. Bariatric surgery and hypertension: implications and perspectives after the GATEWAY randomized trial. Cardiovasc Diagn Ther. 2019;9(1):100–3.PubMedPubMedCentral
27.
Zurück zum Zitat Chung F, Abdullah HR, Liao P. STOP-Bang questionnaire: a practical approach to screen for obstructive sleep apnea. Chest. 2016;149(3):631–8.PubMed Chung F, Abdullah HR, Liao P. STOP-Bang questionnaire: a practical approach to screen for obstructive sleep apnea. Chest. 2016;149(3):631–8.PubMed
28.
Zurück zum Zitat Hamilton GS, Joosten SA. Obstructive sleep apnoea and obesity. Aust Fam Physician. 2017;46(7):460.PubMed Hamilton GS, Joosten SA. Obstructive sleep apnoea and obesity. Aust Fam Physician. 2017;46(7):460.PubMed
29.
Zurück zum Zitat Albeladi B, Bourbao-Tournois C, Huten N. Short- and midterm results between laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy for the treatment of morbid obesity. J Obes. 2013;2:2013. Albeladi B, Bourbao-Tournois C, Huten N. Short- and midterm results between laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy for the treatment of morbid obesity. J Obes. 2013;2:2013.
30.
Zurück zum Zitat Bonouvrie DS, Uittenbogaart M, Luijten AA, et al. Lack of standard definitions of primary and secondary (non) responders after primary gastric bypass and gastric sleeve: a systematic review. Obes Surg. 2019;29(2):691–7.PubMed Bonouvrie DS, Uittenbogaart M, Luijten AA, et al. Lack of standard definitions of primary and secondary (non) responders after primary gastric bypass and gastric sleeve: a systematic review. Obes Surg. 2019;29(2):691–7.PubMed
31.
Zurück zum Zitat Diamantis T, Apostolou KG, Alexandrou A, et al. Review of long-term weight loss results after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10(1):177–83.PubMed Diamantis T, Apostolou KG, Alexandrou A, et al. Review of long-term weight loss results after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10(1):177–83.PubMed
32.
Zurück zum Zitat Artero A, Martinez-Ibanez J, Civera M, et al. Anthropometric parameters and permanent remission of comorbidities 10 years after open gastric bypass in a cohort with high prevalence of super-obesity. Endocrinol Diab Nutr. 2017;64(6):310–6. Artero A, Martinez-Ibanez J, Civera M, et al. Anthropometric parameters and permanent remission of comorbidities 10 years after open gastric bypass in a cohort with high prevalence of super-obesity. Endocrinol Diab Nutr. 2017;64(6):310–6.
33.
Zurück zum Zitat Himpens J, Dobbeleir J, Peeters G. Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg. 2010;252(2):319–24.PubMed Himpens J, Dobbeleir J, Peeters G. Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg. 2010;252(2):319–24.PubMed
34.
Zurück zum Zitat Noel P, Nedelcu M, Nocca D, et al. Revised sleeve gastrectomy: another option for weight loss failure after sleeve gastrectomy. Surg Endosc. 2014;28(4):1096–102.PubMed Noel P, Nedelcu M, Nocca D, et al. Revised sleeve gastrectomy: another option for weight loss failure after sleeve gastrectomy. Surg Endosc. 2014;28(4):1096–102.PubMed
35.
Zurück zum Zitat Bohdjalian A, Langer FB, Shakeri-Leidenmühler S, et al. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg. 2010;20(5):535–40.PubMed Bohdjalian A, Langer FB, Shakeri-Leidenmühler S, et al. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg. 2010;20(5):535–40.PubMed
36.
Zurück zum Zitat Saliba C, El Rayes J, Diab S, et al. Weight regain after sleeve gastrectomy: a look at the benefits of re-sleeve. Cureus. 2018;10(10) Saliba C, El Rayes J, Diab S, et al. Weight regain after sleeve gastrectomy: a look at the benefits of re-sleeve. Cureus. 2018;10(10)
37.
Zurück zum Zitat Weiner RA, Weiner S, Pomhoff I, et al. Laparoscopic sleeve gastrectomy—influence of sleeve size and resected gastric volume. Obes Surg. 2007;17(10):1297–305.PubMed Weiner RA, Weiner S, Pomhoff I, et al. Laparoscopic sleeve gastrectomy—influence of sleeve size and resected gastric volume. Obes Surg. 2007;17(10):1297–305.PubMed
38.
Zurück zum Zitat Iannelli A, Schneck AS, Noel P, et al. Re-sleeve gastrectomy for failed laparoscopic sleeve gastrectomy: a feasibility study. Obes Surg. 2011;21(7):832–5.PubMed Iannelli A, Schneck AS, Noel P, et al. Re-sleeve gastrectomy for failed laparoscopic sleeve gastrectomy: a feasibility study. Obes Surg. 2011;21(7):832–5.PubMed
39.
Zurück zum Zitat Baig SJ, Priya P, Mahawar KK, et al. Weight regain after bariatric surgery—a multicentre study of 9617 patients from Indian Bariatric Surgery Outcome Reporting Group. Obes Surg. 2019;7:1. Baig SJ, Priya P, Mahawar KK, et al. Weight regain after bariatric surgery—a multicentre study of 9617 patients from Indian Bariatric Surgery Outcome Reporting Group. Obes Surg. 2019;7:1.
40.
Zurück zum Zitat Livhits M, Mercado C, Yermilov I, et al. Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes Surg. 2012;22(1):70–89.PubMed Livhits M, Mercado C, Yermilov I, et al. Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes Surg. 2012;22(1):70–89.PubMed
41.
Zurück zum Zitat Abbatini F, Capoccia D, Casella G, et al. Long-term remission of type 2 diabetes in morbidly obese patients after sleeve gastrectomy. Surg Obes Relat Dis. 2013;9(4):498–502.PubMed Abbatini F, Capoccia D, Casella G, et al. Long-term remission of type 2 diabetes in morbidly obese patients after sleeve gastrectomy. Surg Obes Relat Dis. 2013;9(4):498–502.PubMed
42.
Zurück zum Zitat Viscido G, Gorodner V, Signorini FJ, et al. Obese patients with type 2 diabetes: outcomes after laparoscopic sleeve gastrectomy. J Laparoendosc Adv Surg Tech. 2019;29(5):655–62. Viscido G, Gorodner V, Signorini FJ, et al. Obese patients with type 2 diabetes: outcomes after laparoscopic sleeve gastrectomy. J Laparoendosc Adv Surg Tech. 2019;29(5):655–62.
43.
Zurück zum Zitat Cho JM, Kim HJ, Menzo EL, et al. Effect of sleeve gastrectomy on type 2 diabetes as an alternative treatment modality to Roux-en-Y gastric bypass: systemic review and meta-analysis. Surg Obes Relat Dis. 2015;11(6):1273–80.PubMed Cho JM, Kim HJ, Menzo EL, et al. Effect of sleeve gastrectomy on type 2 diabetes as an alternative treatment modality to Roux-en-Y gastric bypass: systemic review and meta-analysis. Surg Obes Relat Dis. 2015;11(6):1273–80.PubMed
44.
Zurück zum Zitat Lingvay I, Guth E, Islam A, et al. Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery? Diabetes Care. 2013;36(9):2741–7.PubMedPubMedCentral Lingvay I, Guth E, Islam A, et al. Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery? Diabetes Care. 2013;36(9):2741–7.PubMedPubMedCentral
45.
Zurück zum Zitat Laferrère B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;93(7):2479–85.PubMedPubMedCentral Laferrère B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;93(7):2479–85.PubMedPubMedCentral
46.
Zurück zum Zitat Robert M, Ferrand-Gaillard C, Disse E, et al. Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: impact of surgical techniques. Obes Surg. 2013;23(6):770–5.PubMed Robert M, Ferrand-Gaillard C, Disse E, et al. Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: impact of surgical techniques. Obes Surg. 2013;23(6):770–5.PubMed
47.
Zurück zum Zitat Zenti MG, Rubbo I, Ceradini G, et al. Clinical factors that predict remission of diabetes after different bariatric surgical procedures: interdisciplinary group of bariatric surgery of Verona (GICOV). Acta Diabetol. 2015;52(5):937–42.PubMed Zenti MG, Rubbo I, Ceradini G, et al. Clinical factors that predict remission of diabetes after different bariatric surgical procedures: interdisciplinary group of bariatric surgery of Verona (GICOV). Acta Diabetol. 2015;52(5):937–42.PubMed
48.
Zurück zum Zitat Robertson RP, Harmon J, Tran PO, et al. β-Cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes. 2004;53(suppl 1):S119–24.PubMed Robertson RP, Harmon J, Tran PO, et al. β-Cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes. 2004;53(suppl 1):S119–24.PubMed
49.
Zurück zum Zitat Raj PP, Bhattacharya S, Kumar SS, et al. Do bariatric surgery-related type 2 diabetes remission predictors add clinical value? A study on Asian Indian obese diabetics. Obes Surg. 2017;27(8):2113–9. Raj PP, Bhattacharya S, Kumar SS, et al. Do bariatric surgery-related type 2 diabetes remission predictors add clinical value? A study on Asian Indian obese diabetics. Obes Surg. 2017;27(8):2113–9.
50.
Zurück zum Zitat English TM, Malkani S, Kinney RL, et al. Predicting remission of diabetes after RYGB surgery following intensive management to optimize preoperative glucose control. Obes Surg. 2015;25(1):1–6.PubMed English TM, Malkani S, Kinney RL, et al. Predicting remission of diabetes after RYGB surgery following intensive management to optimize preoperative glucose control. Obes Surg. 2015;25(1):1–6.PubMed
51.
Zurück zum Zitat Bruno G, Gruden G, Barutta F, et al. What is the impact of sleeve gastrectomy and gastric bypass on metabolic control of diabetes? A clinic-based cohort of Mediterranean diabetic patients. Surg Obes Relat Dis. 2015;11(5):1014–9.PubMed Bruno G, Gruden G, Barutta F, et al. What is the impact of sleeve gastrectomy and gastric bypass on metabolic control of diabetes? A clinic-based cohort of Mediterranean diabetic patients. Surg Obes Relat Dis. 2015;11(5):1014–9.PubMed
52.
Zurück zum Zitat Skancke M, Schoolfield C, Grossman R, et al. Laparoscopic sleeve gastrectomy for morbid obesity at a Veterans Affairs medical center. J Laparoendosc Adv Surg Tech. 2018;28(6):650–5. Skancke M, Schoolfield C, Grossman R, et al. Laparoscopic sleeve gastrectomy for morbid obesity at a Veterans Affairs medical center. J Laparoendosc Adv Surg Tech. 2018;28(6):650–5.
53.
Zurück zum Zitat Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378–84.PubMed Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378–84.PubMed
54.
Zurück zum Zitat Raj PP, Gomes RM, Kumar S, et al. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians:“NASHOST” prospective observational trial. Surg Obes Relat Dis. 2015;11(6):1315–22. Raj PP, Gomes RM, Kumar S, et al. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians:“NASHOST” prospective observational trial. Surg Obes Relat Dis. 2015;11(6):1315–22.
55.
Zurück zum Zitat Luo RB, Suzuki T, Hooker JC, et al. How bariatric surgery affects liver volume and fat density in NAFLD patients. Surg Endosc. 2018;32(4):1675–82.PubMed Luo RB, Suzuki T, Hooker JC, et al. How bariatric surgery affects liver volume and fat density in NAFLD patients. Surg Endosc. 2018;32(4):1675–82.PubMed
56.
Zurück zum Zitat Koh ZJ, Salgaonkar HP, Lee WJ, et al. Improvement in non-alcoholic fatty liver disease score correlates with weight loss in obese patients undergoing laparoscopic sleeve gastrectomy: a two-centre study from an Asian cohort. Obes Surg. 2019;29(3):862–8.PubMed Koh ZJ, Salgaonkar HP, Lee WJ, et al. Improvement in non-alcoholic fatty liver disease score correlates with weight loss in obese patients undergoing laparoscopic sleeve gastrectomy: a two-centre study from an Asian cohort. Obes Surg. 2019;29(3):862–8.PubMed
57.
Zurück zum Zitat Hasan MY, Lomanto D, Loh LL, et al. Gallstone disease after laparoscopic sleeve gastrectomy in an Asian population—what proportion of gallstones actually becomes symptomatic? Obes Surg. 2017;27(9):2419–23.PubMed Hasan MY, Lomanto D, Loh LL, et al. Gallstone disease after laparoscopic sleeve gastrectomy in an Asian population—what proportion of gallstones actually becomes symptomatic? Obes Surg. 2017;27(9):2419–23.PubMed
58.
Zurück zum Zitat Coupaye M, Castel B, Sami O, et al. Comparison of the incidence of cholelithiasis after sleeve gastrectomy and Roux-en-Y gastric bypass in obese patients: a prospective study. Surg Obes Relat Dis. 2015;11(4):779–84.PubMed Coupaye M, Castel B, Sami O, et al. Comparison of the incidence of cholelithiasis after sleeve gastrectomy and Roux-en-Y gastric bypass in obese patients: a prospective study. Surg Obes Relat Dis. 2015;11(4):779–84.PubMed
59.
Zurück zum Zitat Uy MC, Talingdan-Te MC, Espinosa WZ, et al. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis. Obes Surg. 2008;18(12):1532–8.PubMed Uy MC, Talingdan-Te MC, Espinosa WZ, et al. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis. Obes Surg. 2008;18(12):1532–8.PubMed
60.
Zurück zum Zitat Yehoshua RT, Eidelman LA, Stein M, et al. Laparoscopic sleeve gastrectomy—volume and pressure assessment. Obes Surg. 2008;18(9):1083–8.PubMed Yehoshua RT, Eidelman LA, Stein M, et al. Laparoscopic sleeve gastrectomy—volume and pressure assessment. Obes Surg. 2008;18(9):1083–8.PubMed
61.
Zurück zum Zitat Saglam K, Aktas A, Gundogan E, et al. Management of acute sleeve gastrectomy leaks by conversion to Roux-en-Y gastric bypass: a small case series. Obes Surg. 2017;27(11):3061–3.PubMed Saglam K, Aktas A, Gundogan E, et al. Management of acute sleeve gastrectomy leaks by conversion to Roux-en-Y gastric bypass: a small case series. Obes Surg. 2017;27(11):3061–3.PubMed
62.
Zurück zum Zitat Praveenraj P, Gomes RM, Kumar S, et al. Management of gastric leaks after laparoscopic sleeve gastrectomy for morbid obesity: a tertiary care experience and design of a management algorithm. J Minim Access Surg. 2016;12(4):342.PubMedPubMedCentral Praveenraj P, Gomes RM, Kumar S, et al. Management of gastric leaks after laparoscopic sleeve gastrectomy for morbid obesity: a tertiary care experience and design of a management algorithm. J Minim Access Surg. 2016;12(4):342.PubMedPubMedCentral
63.
Zurück zum Zitat Zafar SN, Felton J, Miller K, et al. Staple line treatment and bleeding after laparoscopic sleeve gastrectomy. J Soc Laparoendosc Surg. 2018;22(4)PubMedPubMedCentral Zafar SN, Felton J, Miller K, et al. Staple line treatment and bleeding after laparoscopic sleeve gastrectomy. J Soc Laparoendosc Surg. 2018;22(4)PubMedPubMedCentral
64.
Zurück zum Zitat Praveenraj P, Gomes RM, Kumar S, et al. Management of type 1 late sleeve leak with gastrobronchial fistula by laparoscopic suturing and conversion to Roux-en-Y gastric bypass: video report. Obes Surg. 2015;25(12):2462.PubMed Praveenraj P, Gomes RM, Kumar S, et al. Management of type 1 late sleeve leak with gastrobronchial fistula by laparoscopic suturing and conversion to Roux-en-Y gastric bypass: video report. Obes Surg. 2015;25(12):2462.PubMed
65.
Zurück zum Zitat Abraham A, Virdi RP, Rajan D, et al. Gastrobronchial fistula following laparoscopic sleeve gastrectomy. BMJ Case Rep. 2012;2012:bcr2012006789.PubMedPubMedCentral Abraham A, Virdi RP, Rajan D, et al. Gastrobronchial fistula following laparoscopic sleeve gastrectomy. BMJ Case Rep. 2012;2012:bcr2012006789.PubMedPubMedCentral
66.
Zurück zum Zitat Dhorepatil AS, Cottam D, Surve A, et al. Is pneumatic balloon dilation safe and effective primary modality of treatment for post-sleeve gastrectomy strictures? A retrospective study. BMC Surg. 2018;18(1):52.PubMedPubMedCentral Dhorepatil AS, Cottam D, Surve A, et al. Is pneumatic balloon dilation safe and effective primary modality of treatment for post-sleeve gastrectomy strictures? A retrospective study. BMC Surg. 2018;18(1):52.PubMedPubMedCentral
67.
Zurück zum Zitat Manos T, Nedelcu M, Cotirlet A, et al. How to treat stenosis after sleeve gastrectomy? Surg Obes Relat Dis. 2017;13(2):150–4.PubMed Manos T, Nedelcu M, Cotirlet A, et al. How to treat stenosis after sleeve gastrectomy? Surg Obes Relat Dis. 2017;13(2):150–4.PubMed
68.
Zurück zum Zitat Iannelli A, Debs T, Martini F, et al. Laparoscopic conversion of sleeve gastrectomy to Roux-en-Y gastric bypass: indications and preliminary results. Surg Obes Relat Dis. 2016;12(8):1533–8.PubMed Iannelli A, Debs T, Martini F, et al. Laparoscopic conversion of sleeve gastrectomy to Roux-en-Y gastric bypass: indications and preliminary results. Surg Obes Relat Dis. 2016;12(8):1533–8.PubMed
Metadaten
Titel
Long-term outcomes of laparoscopic sleeve gastrectomy from the Indian subcontinent
verfasst von
Shivanshu Misra
Siddhartha Bhattacharya
S. Saravana Kumar
B. Deepa Nandhini
S. Christinajoice Saminathan
P. Praveen Raj
Publikationsdatum
05.08.2019
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 12/2019
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-04103-z

Weitere Artikel der Ausgabe 12/2019

Obesity Surgery 12/2019 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.